US Stock MarketDetailed Quotes

LEXX Lexaria Bioscience

Watchlist
  • 2.2600
  • -0.0800-3.42%
Close Dec 12 16:00 ET
  • 2.5000
  • +0.2400+10.62%
Pre 08:23 ET
39.44MMarket Cap-4.81P/E (TTM)

Lexaria Bioscience Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Aug 31, 2024
(Q4)Aug 31, 2024
(Q3)May 31, 2024
(Q2)Feb 29, 2024
(Q1)Nov 30, 2023
(FY)Aug 31, 2023
(Q4)Aug 31, 2023
(Q3)May 31, 2023
(Q2)Feb 28, 2023
(Q1)Nov 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
15.68%-4.96M
-16.65%-1.89M
29.11%-1.27M
49.55%-619.61K
5.11%-1.18M
-20.53%-5.88M
-37.83%-1.62M
-41.84%-1.79M
3.84%-1.23M
-6.77%-1.25M
Net income from continuing operations
13.47%-5.81M
-75.06%-2.19M
25.14%-1.78M
50.20%-652.73K
33.02%-1.19M
9.09%-6.71M
17.46%-1.25M
1.44%-2.38M
9.53%-1.31M
11.69%-1.77M
Depreciation and amortization
-47.62%76.15K
-110.94%-7.76K
56.75%39.2K
-35.58%15.93K
16.37%28.78K
41.55%145.4K
186.79%70.93K
4.68%25.01K
-5.48%24.73K
-11.46%24.73K
Other non cash items
-10.31%39.28K
208.49%33.77K
-214.13%-14.79K
-9.12%18.3K
878.43%1.99K
-96.48%43.79K
-98.21%10.95K
-95.83%12.96K
-93.52%20.14K
-102.33%-255
Change In working capital
-25.62%106.56K
124.36%174.13K
-84.10%76.32K
-137.46%-9.35K
-138.10%-134.55K
140.76%143.26K
-53.81%-714.85K
181.14%480.04K
123.36%24.96K
614.39%353.11K
-Change in receivables
-290.54%-50.57K
1,660.55%46.21K
451.00%124.56K
24.87%186.71K
-382.68%-408.05K
119.30%26.54K
93.69%-2.96K
-148.19%-35.49K
431.47%149.53K
29.03%-84.54K
-Change in inventory
--0
--0
--0
--0
--0
2,276.30%43.07K
--0
216.44%9.36K
171.71%2.92K
956.66%30.79K
-Change in prepaid assets
-2,238.35%-641.03K
-1,074.33%-808.27K
63.65%-112.75K
-126.98%-134.49K
30.99%414.47K
111.64%29.98K
119.78%82.96K
-579.71%-310.15K
-488.21%-59.25K
285.74%316.42K
-Change in payables and accrued expense
833.95%826.47K
219.65%937.62K
-91.19%73.47K
16.24%-43.65K
-255.87%-140.97K
94.48%88.49K
-13,829.01%-783.65K
1,959.61%833.81K
28.56%-52.12K
8.19%90.44K
-Change in other current liabilities
25.75%-33.27K
42.95%-6.39K
32.20%-8.96K
----
----
---44.81K
---11.2K
---13.21K
----
----
-Change in other working capital
--4.96K
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
15.68%-4.96M
-16.65%-1.89M
29.11%-1.27M
49.55%-619.61K
5.11%-1.18M
-20.53%-5.88M
-37.83%-1.62M
-41.84%-1.79M
3.84%-1.23M
-6.77%-1.25M
Investing cash flow
Cash flow from continuing investing activities
-11.20%-188.61K
-1.68%-69.59K
34.61%-22K
-74.37%-56.99K
-14.88%-40.03K
6.11%-169.61K
-36.75%-68.44K
11.35%-33.65K
5.05%-32.68K
40.15%-34.84K
Net PPE purchase and sale
-27.46%-43.01K
---43.01K
--0
--0
--0
31.40%-33.75K
--0
--0
---13.25K
51.62%-20.5K
Net intangibles purchase and sale
-7.16%-145.59K
61.17%-26.57K
34.61%-22K
-193.22%-56.99K
-179.08%-40.03K
-3.36%-135.86K
-36.76%-68.44K
-8.04%-33.65K
43.54%-19.44K
9.46%-14.34K
Cash from discontinued investing activities
Investing cash flow
-11.20%-188.61K
-1.68%-69.59K
34.61%-22K
-74.37%-56.99K
-14.88%-40.03K
6.11%-169.61K
-36.75%-68.44K
11.35%-33.65K
5.05%-32.68K
40.15%-34.84K
Financing cash flow
Cash flow from continuing financing activities
548.86%10.32M
0
194.67%5.04M
3.45M
1.82M
3,664.42%1.59M
-986.01%-121.69K
15,375.06%1.71M
0
0
Net common stock issuance
164.74%4.21M
--0
--0
--2.96M
--1.25M
--1.59M
---121.69K
--1.71M
--0
--0
Proceeds from stock option exercised by employees
--6.11M
--0
--5.04M
--491.82K
--571.65K
--0
--0
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
548.86%10.32M
--0
194.67%5.04M
--3.45M
--1.82M
3,664.42%1.59M
-986.01%-121.69K
15,375.06%1.71M
--0
--0
Net cash flow
Beginning cash position
-76.74%1.35M
167.36%8.46M
43.80%4.71M
-56.89%1.95M
-76.74%1.35M
-46.75%5.81M
-55.13%3.16M
-60.86%3.27M
-53.18%4.53M
-46.75%5.81M
Current changes in cash
215.84%5.17M
-8.25%-1.96M
3,570.48%3.75M
320.17%2.78M
146.69%597.69K
12.61%-4.46M
-46.37%-1.81M
91.73%-108.2K
4.68%-1.26M
-3.61%-1.28M
Effect of exchange rate changes
---19.82K
--2.05K
---1.24K
---25K
--4.37K
--0
--0
----
----
--0
End cash Position
380.72%6.5M
380.72%6.5M
167.36%8.46M
43.80%4.71M
-56.89%1.95M
-76.74%1.35M
-76.74%1.35M
-55.13%3.16M
-60.86%3.27M
-53.18%4.53M
Free cash flow
14.93%-5.15M
-16.04%-1.96M
29.21%-1.29M
46.34%-676.6K
4.57%-1.22M
-19.58%-6.05M
-37.78%-1.69M
-40.28%-1.82M
3.87%-1.26M
-4.54%-1.28M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Aug 31, 2024(Q4)Aug 31, 2024(Q3)May 31, 2024(Q2)Feb 29, 2024(Q1)Nov 30, 2023(FY)Aug 31, 2023(Q4)Aug 31, 2023(Q3)May 31, 2023(Q2)Feb 28, 2023(Q1)Nov 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 15.68%-4.96M-16.65%-1.89M29.11%-1.27M49.55%-619.61K5.11%-1.18M-20.53%-5.88M-37.83%-1.62M-41.84%-1.79M3.84%-1.23M-6.77%-1.25M
Net income from continuing operations 13.47%-5.81M-75.06%-2.19M25.14%-1.78M50.20%-652.73K33.02%-1.19M9.09%-6.71M17.46%-1.25M1.44%-2.38M9.53%-1.31M11.69%-1.77M
Depreciation and amortization -47.62%76.15K-110.94%-7.76K56.75%39.2K-35.58%15.93K16.37%28.78K41.55%145.4K186.79%70.93K4.68%25.01K-5.48%24.73K-11.46%24.73K
Other non cash items -10.31%39.28K208.49%33.77K-214.13%-14.79K-9.12%18.3K878.43%1.99K-96.48%43.79K-98.21%10.95K-95.83%12.96K-93.52%20.14K-102.33%-255
Change In working capital -25.62%106.56K124.36%174.13K-84.10%76.32K-137.46%-9.35K-138.10%-134.55K140.76%143.26K-53.81%-714.85K181.14%480.04K123.36%24.96K614.39%353.11K
-Change in receivables -290.54%-50.57K1,660.55%46.21K451.00%124.56K24.87%186.71K-382.68%-408.05K119.30%26.54K93.69%-2.96K-148.19%-35.49K431.47%149.53K29.03%-84.54K
-Change in inventory --0--0--0--0--02,276.30%43.07K--0216.44%9.36K171.71%2.92K956.66%30.79K
-Change in prepaid assets -2,238.35%-641.03K-1,074.33%-808.27K63.65%-112.75K-126.98%-134.49K30.99%414.47K111.64%29.98K119.78%82.96K-579.71%-310.15K-488.21%-59.25K285.74%316.42K
-Change in payables and accrued expense 833.95%826.47K219.65%937.62K-91.19%73.47K16.24%-43.65K-255.87%-140.97K94.48%88.49K-13,829.01%-783.65K1,959.61%833.81K28.56%-52.12K8.19%90.44K
-Change in other current liabilities 25.75%-33.27K42.95%-6.39K32.20%-8.96K-----------44.81K---11.2K---13.21K--------
-Change in other working capital --4.96K------------------------------------
Cash from discontinued investing activities
Operating cash flow 15.68%-4.96M-16.65%-1.89M29.11%-1.27M49.55%-619.61K5.11%-1.18M-20.53%-5.88M-37.83%-1.62M-41.84%-1.79M3.84%-1.23M-6.77%-1.25M
Investing cash flow
Cash flow from continuing investing activities -11.20%-188.61K-1.68%-69.59K34.61%-22K-74.37%-56.99K-14.88%-40.03K6.11%-169.61K-36.75%-68.44K11.35%-33.65K5.05%-32.68K40.15%-34.84K
Net PPE purchase and sale -27.46%-43.01K---43.01K--0--0--031.40%-33.75K--0--0---13.25K51.62%-20.5K
Net intangibles purchase and sale -7.16%-145.59K61.17%-26.57K34.61%-22K-193.22%-56.99K-179.08%-40.03K-3.36%-135.86K-36.76%-68.44K-8.04%-33.65K43.54%-19.44K9.46%-14.34K
Cash from discontinued investing activities
Investing cash flow -11.20%-188.61K-1.68%-69.59K34.61%-22K-74.37%-56.99K-14.88%-40.03K6.11%-169.61K-36.75%-68.44K11.35%-33.65K5.05%-32.68K40.15%-34.84K
Financing cash flow
Cash flow from continuing financing activities 548.86%10.32M0194.67%5.04M3.45M1.82M3,664.42%1.59M-986.01%-121.69K15,375.06%1.71M00
Net common stock issuance 164.74%4.21M--0--0--2.96M--1.25M--1.59M---121.69K--1.71M--0--0
Proceeds from stock option exercised by employees --6.11M--0--5.04M--491.82K--571.65K--0--0--0--0--0
Cash from discontinued financing activities
Financing cash flow 548.86%10.32M--0194.67%5.04M--3.45M--1.82M3,664.42%1.59M-986.01%-121.69K15,375.06%1.71M--0--0
Net cash flow
Beginning cash position -76.74%1.35M167.36%8.46M43.80%4.71M-56.89%1.95M-76.74%1.35M-46.75%5.81M-55.13%3.16M-60.86%3.27M-53.18%4.53M-46.75%5.81M
Current changes in cash 215.84%5.17M-8.25%-1.96M3,570.48%3.75M320.17%2.78M146.69%597.69K12.61%-4.46M-46.37%-1.81M91.73%-108.2K4.68%-1.26M-3.61%-1.28M
Effect of exchange rate changes ---19.82K--2.05K---1.24K---25K--4.37K--0--0----------0
End cash Position 380.72%6.5M380.72%6.5M167.36%8.46M43.80%4.71M-56.89%1.95M-76.74%1.35M-76.74%1.35M-55.13%3.16M-60.86%3.27M-53.18%4.53M
Free cash flow 14.93%-5.15M-16.04%-1.96M29.21%-1.29M46.34%-676.6K4.57%-1.22M-19.58%-6.05M-37.78%-1.69M-40.28%-1.82M3.87%-1.26M-4.54%-1.28M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Salesforce
CRM
+0.90%
Apple
AAPL
+0.60%
Microsoft
MSFT
+0.13%
Coinbase
COIN
-0.27%
Meta Platforms
META
-0.30%

Unlock the Full List